The introduction of recombinant tissue plasminogen activator (rtPA, Alteplase) as a clinical thrombolytic agent for acute ischemic stroke (AIS) 25 years ago was a breakthrough in the treatment of strokes caused by clots in the carotid and cerebral arteries 3-5. Here, PLAT is linked to stroke disorder.